How is Reed syndrome treated?
James Olson
Updated on April 01, 2026
Also asked, how rare is Hlrcc?
HLRCC is a rare condition that has been reported in approximately 300 families worldwide.
One may also ask, how is Hlrcc treated? In conclusion, we suggest bevacizumab plus erlotinib be considered a treatment option in patients with metastatic HLRCC-associated RCC, even after failures of mTOR inhibitor and/or VEGFR TKI based therapies.
In this way, what is Reed disease?
Reed's syndrome is a rare genodermatosis characterized by multiple cutaneous leiomyomas and uterine leiomyomas in women. When presenting with renal cell carcinoma, it is labeled as hereditary leiomyomatosis and renal cell cancer.
What is hereditary Leiomyomatosis?
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a hereditary condition associated with the development of multiple leiomyomas (smooth muscle tumors) in the skin and uterus (fibroids) as well as an aggressive form of kidney cancer. HLRCC can look different in patient to patient, ranging from mild to severe.